Gossamer Bio Announces 1-For-80 Reverse Stock Split, Effective September 10
Gossamer Bio, Inc. (NASDAQ:GOSS) (the "Company" or "Gossamer"), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary
Gossamer Bio is combining 80 old shares into 1 new share—like trading 80 pennies for one dollar. This is a common move when a stock price gets very low, but watch whether the company's actual progress on new medicines improves alongside it.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.